As announced already in February, capacity utilization and turnover in Q1 were weighed down by the p...
Redeye is encouraged to see that Impact Coatings has received another order for an IC2000-system for...
I samband med Eisais rapport annonserades att företaget räknar med en försäljning av Leqembi på JPY5...
Redeye comments on Raketech’s Q1-results which were in line with the preliminary outcome that was an...
Redeye comments on Thunderful Group’s Q1'24 report, which was weak and came in line with preliminary...
Aspo’s CMD elaborated on major investment plans as both ESL and Telko will expand their operations a...
Redeye comments on Sozap’s Q1 results, which revealed sales roughly in line with expectations, while...
Sales -3%, EBIT +15%, order book -2% v.s. ABGSCe EBIT margin strengthened to 4.
Redeye provides an research update following Starbreeze Q1-report; Some positive comments from manag...
Redeye updates on EG7 post Q1-results which were weaker than expected owing to soft performance in t...
Redeye is optimistic about the new data from lymphoma patients treated with subcutaneous as well as ...
Redye provides a research update following the Q1 2024 report from Precise Biometrics.
Mixed markets; US strong but Germany weaker '24e-'26e EBIT down 4-3% on lowered Germany estimates Sh...
- Solid start in Q1 - Higher sales commissions weigh down on EBIT in '25e-'26e - Fair value revised ...
- Stark nettoomsättning som uppgick till 3,5 MSEK (2,0) - Stärkt produkterbjudande och ökad funktion...
Aspo held a CMD event on 14 May. The company is heading for EUR 1bn in net sales in 2028 which is al...
Paper EBITDA PLN 109m, in line vs ABGSCe PLN 108m Group EBITDA miss driven by Rottneros Paper market...
Redeye leaves a short comment on the exclusive option and license agreement between AC Immune and Ta...
Active Biotech laddar för två akademiskt ledda studier inom sitt nya huvudområde, myelofibros.
Tessin är en digital investeringsplattform för säkerställda fastighetslån.
